Assessing the Impact of Isoniazid Preventive Therapy (IPT) on Tuberculosis Incidence and Predictors of Tuberculosis among Adult Patients Enrolled on ART in Nekemte Town, Western Ethiopia: A Retrospective Cohort Study
Table 2
Baseline clinical, laboratory results, and followup outcome characteristics of PLWH at Nekemte referral hospital and Nekemte Health center followed from September 2009-September 2012.
Variables(n=600)
Category
Cohort group
Total n (%)
IPT n (%) cohort
Non-IPT cohort n (%)
CD4
<=200
20(10%)
68(11.33%)
88(14.66%)
201-350
64(32%)
119(29.75%)
183(30.5%)
351-500
52(26%)
97(24.25%)
149(24.83%)
>500
64(32%)
116(29%)
180(30%)
BMI
>=18.5
127(63.5%)
229(57.25%)
356(59.33%)
<18.5
73(36.5%)
171(42.75%)
244(40.66%)
Weight
<=50
85(42.5%)
177(44.25%)
266(40.66%)
>50
115(57.5%)
223(55.75%)
338(56.33%)
WHO Stage
I/II
164(82%)
294(73.5%)
458(76.33%)
III/IV
36(18%)
106(26.5%)
142(23.66%)
Functional Status
Working
169(84.5%)
348(87%)
517(86.16%)
Ambulatory/Bedridden
29(14.5%)
43(10.75%)
72(18%)
Opportunistic Infection
Yes
45(22.5%)
80(20%)
125(20.83%)
No
155(77.5%)
320(80%)
475(79.16%)
Cotrimoxazole Treatment
Yes
142(71%)
287(71.75%)
429(71.5%)
No
58(29%)
113(28.25%)
171(28.5%)
Previous TB
Yes
45(22.5%)
80(20%)
125(20.83%)
No
155(77.5%)
320(80%)
475(79.16%)
Outcome status
TB
11(5.5%)
42(10.5%)
53(8.83%)
Censored
189(94.5%)
358(89.5%)
547(91.16%)
Censored: loss to followup, death, transferred out, started IPT (for non-IPT).
